Characteristic | Chemoprevention arm | |||
---|---|---|---|---|
No chemoprevention | Monthly | Daily | Monthly | |
SP | TS | DP | ||
Number of episodes | 992 | 901 | 721 | 444 |
Patient age in months, mean (SD) | 16.0 (5.1) | 16.1 (5.1) | 16.9 (4.8)b | 17.8 (4.5)b |
Female gender, n (%) | 428 (43.2%) | 407 (45.2%) | 344 (47.7%) | 211 (47.5%) |
Urban residence, n (%) | 13 (1.3%) | 26 (2.9%) | 14 (1.9%) | 18 (4.1%) |
Household wealth index, n (%) | ||||
Lowest tertile | 319 (32.2%) | 284 (31.5%) | 308 (42.7%)b | 176 (39.6%)b |
Middle tertile | 381 (38.4%) | 347 (38.5%) | 236 (32.7%) | 149 (33.6%) |
Highest tertile | 292 (29.4%) | 270 (30.0%) | 177 (24.6%) | 119 (26.8%) |
HIV-exposeda, n (%) | 235 (23.7%) | 179 (19.9%) | 114 (15.8%) | 81 (18.2%) |
Temperature °C, mean (SD) | 38.0 (1.0) | 37.9 (1.0) | 37.9 (1.0) | 37.9 (1.0) |
Parasite density per μL, geometric mean | 16321 | 15257 | 11702b | 16841 |
Gametocytes present, n (%) | 41 (4.1%) | 34 (3.8%) | 48 (6.7%)b | 11 (2.5%) |
Haemoglobin g/dL, mean (SD) | 9.7 (1.3) | 9.6 (1.4) | 9.8 (1.3) | 9.9 (1.2) |
Days since last dose of chemopreventive drug assigned, median (IQR) | N/A | 17 (10–24) | 1 (1–1) | 16 (8–23) |
Proportion of prior dose of chemopreventive drug reported taken | N/A | 95.5% | 98.6% | 96.0% |